CoChat

Citrulline a More Suitable Substrate than Arginine to Restore NO Production and the Microcirculation during Endotoxemia

Open access

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Impaired microcirculation during endotoxemia correlates with a disturbed arginine-nitric oxide (NO) metabolism and is associated with deteriorating organ function. Improving the organ perfusion in endotoxemia, as often seen in patients with severe infection or systemic inflammatory response syndrome (SIRS) is, therefore, an important therapeutic target. We hypothesized that supplementation of the arginine precursor citrulline rather than arginine would specifically increase eNOS-induced intracellular NO production and thereby improve the microcirculation during endotoxemia. METHODOLOGY/PRINCIPAL FINDINGS: To study the effects of L-Citrulline and L-Arginine supplementation on jejunal microcirculation, intracellular arginine availability and NO production in a non-lethal prolonged endotoxemia model in mice. C57/Bl6 mice received an 18 hrs intravenous infusion of endotoxin (LPS, 0.4 µg • g bodyweight(-1) • h(-1)), combined with either L-Citrulline (6.25 mg • h-1), L-Arginine (6.25 mg • h(-1)), or L-Alanine (isonitrogenous control; 12.5 mg • h(-1)) during the last 6 hrs. The control group received an 18 hrs sterile saline infusion combined with L-Alanine or L-Citrulline during the last 6 hrs. The microcirculation was evaluated at the end of the infusion period using sidestream dark-field imaging of jejunal villi. Plasma and jejunal tissue amino-acid concentrations were measured by HPLC, NO tissue concentrations by electron-spin resonance spectroscopy and NOS protein concentrations using Western blot. CONCLUSION/SIGNIFICANCE: L-Citrulline supplementation during endotoxemia positively influenced the intestinal microvascular perfusion compared to L-Arginine-supplemented and control endotoxemic mice. L-Citrulline supplementation increased plasma and tissue concentrations of arginine and citrulline, and restored intracellular NO production in the intestine. L-Arginine supplementation did not increase the intracellular arginine availability. Jejunal tissues in the L-Citrulline-supplemented group showed, compared to the endotoxemic and L-Arginine-supplemented endotoxemic group, an increase in degree of phosphorylation of eNOS (Ser 1177) and a decrease in iNOS protein level. In conclusion, L-Citrulline supplementation during endotoxemia and not L-Arginine reduced intestinal microcirculatory dysfunction and increased intracellular NO production, likely via increased intracellular citrulline and arginine availability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0037439

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Experimental set up of the prolonged endotoxemia model. Mice were fitted with a jugular vein cannula at t = 0 d. After 4 days (t = 4 d) an 18hours continuous infusion with lipopolysaccharides (LPS) was started, which was combined during the last 6 hours with an infusion of Citrulline (Cit), Arginine (Arg) or an isonitrogenous quantity of the placebo Alanine (Ala). After completing the treatment, sidestream dark-field (SDF) imaging was used to quantify the microcirculation in the jejunal villi or Nitric Oxide (NO) spin trapping with iron-diethyldithiocarbamate (DETC) complexes to measure NO production in vivo.
Figure 1 Experimental set up of the prolonged endotoxemia model. Mice were fitted with a jugular vein cannula at t = 0 d. After 4 days (t = 4 d) an 18hours continuous infusion with lipopolysaccharides (LPS) was started, which was combined during the last 6 hours with an infusion of Citrulline (Cit), Arginine (Arg) or an isonitrogenous quantity of the placebo Alanine (Ala). After completing the treatment, sidestream dark-field (SDF) imaging was used to quantify the microcirculation in the jejunal villi or Nitric Oxide (NO) spin trapping with iron-diethyldithiocarbamate (DETC) complexes to measure NO production in vivo.CC BY · PubMed Central
Figure 2 Circulation measurements with SDF imaging in the control, LPS-Ala, LPS-Arg and LPS-Cit groups. (A) L-Citrulline supplementation improved the number (mean±SEM) of measurable perfused vessels in the jejunal microcirculation during endotoxemia, (B) in particular of vessels with a diameter ≤10 µm (P<0.01), compared to LPS-Ala and LPS-Arg supplemented animals. (C) The total number of perfused vessels per villus and (D) microcirculatory vessels with a diameter ≤10 µm per villus were also significantly lower in the LPS-Ala and LPS-Arg supplemented animals compared to the control and LPS-Cit group.
Figure 2 Circulation measurements with SDF imaging in the control, LPS-Ala, LPS-Arg and LPS-Cit groups. (A) L-Citrulline supplementation improved the number (mean±SEM) of measurable perfused vessels in the jejunal microcirculation during endotoxemia, (B) in particular of vessels with a diameter ≤10 µm (P<0.01), compared to LPS-Ala and LPS-Arg supplemented animals. (C) The total number of perfused vessels per villus and (D) microcirculatory vessels with a diameter ≤10 µm per villus were also significantly lower in the LPS-Ala and LPS-Arg supplemented animals compared to the control and LPS-Cit group.CC BY · PubMed Central
Figure 3 Representative live images of the microcirculatory measurements in jejunal villi with SDF imaging. (A) Representative live image of the jejunal microcirculation in a control mouse. (B) Representative live image of the jejunal microcirculation in a LPS-Ala treated mouse which shows only perfusion of the larger vessels. (C) Representative live image of a LPS-Arg treated mouse which shows a comparable perfusion pattern as the LPS-Ala treated mouse. (D) Representative live image of a LPS-Cit treated mouse, which’s shows more small perfused vessels per villus.
Figure 3 Representative live images of the microcirculatory measurements in jejunal villi with SDF imaging. (A) Representative live image of the jejunal microcirculation in a control mouse. (B) Representative live image of the jejunal microcirculation in a LPS-Ala treated mouse which shows only perfusion of the larger vessels. (C) Representative live image of a LPS-Arg treated mouse which shows a comparable perfusion pattern as the LPS-Ala treated mouse. (D) Representative live image of a LPS-Cit treated mouse, which’s shows more small perfused vessels per villus.CC BY · PubMed Central
Figure 4 Amino-acid concentrations in plasma. (A) Citrulline plasma concentrations increased after L-Citrulline supplementation (LPS-Cit) compared to all other groups (P<0.0001). (B) Plasma arginine concentrations were significantly reduced in the LPS-Ala group compared to the control group (P<0.05), whereas this concentration was significantly increased by L-Arginine or L-Citrulline supplementation (LPS-Arg and LPS-Cit group) compared to both other groups (P<0.001). (C) Plasma ornithine levels increased in the LPS-Ala treated group compared to the control group (P<0.05) and increased further upon L-Arginine or L-Citrulline supplementation.
Figure 4 Amino-acid concentrations in plasma. (A) Citrulline plasma concentrations increased after L-Citrulline supplementation (LPS-Cit) compared to all other groups (P<0.0001). (B) Plasma arginine concentrations were significantly reduced in the LPS-Ala group compared to the control group (P<0.05), whereas this concentration was significantly increased by L-Arginine or L-Citrulline supplementation (LPS-Arg and LPS-Cit group) compared to both other groups (P<0.001). (C) Plasma ornithine levels increased in the LPS-Ala treated group compared to the control group (P<0.05) and increased further upon L-Arginine or L-Citrulline supplementation.CC BY · PubMed Central
Figure 5 Amino-acid concentrations and NO production in murine jejunal tissue. (A) L-Citrulline supplementation (LPS-Cit) increased tissue citrulline concentration compared to the LPS-Ala, LPS-Arg and control groups (P<0.001) (B) Arginine concentrations were significantly reduced in the LPS-Ala group compared to the control group (P<0.05). Interestingly, this concentration was not increased by L-Arginine supplementation (LPS-Arg), whereas this concentration was significantly increased by L-Citrulline supplementation (LPS-Cit group; P<0.01). (C) Ornithine levels increased in the LPS-Ala treated group compared to the control group (P<0.05) and increased further upon L-Citrulline supplementation (P<0.0001 relative to the control group and P<0.05 relative to the LPS group). (D) In the jejunum, prolonged endotoxemia resulted in a significant decrease in NO production (measured as pmol mono-nitrosyl-iron complexes (MNIC)/mg wet tissue) compared to control (P<0.05). NO production was significantly improved in the LPS-Arg and LPS-Cit group compared to the LPS group (P<0.0001 and P<0.05 respectively).
Figure 5 Amino-acid concentrations and NO production in murine jejunal tissue. (A) L-Citrulline supplementation (LPS-Cit) increased tissue citrulline concentration compared to the LPS-Ala, LPS-Arg and control groups (P<0.001) (B) Arginine concentrations were significantly reduced in the LPS-Ala group compared to the control group (P<0.05). Interestingly, this concentration was not increased by L-Arginine supplementation (LPS-Arg), whereas this concentration was significantly increased by L-Citrulline supplementation (LPS-Cit group; P<0.01). (C) Ornithine levels increased in the LPS-Ala treated group compared to the control group (P<0.05) and increased further upon L-Citrulline supplementation (P<0.0001 relative to the control group and P<0.05 relative to the LPS group). (D) In the jejunum, prolonged endotoxemia resulted in a significant decrease in NO production (measured as pmol mono-nitrosyl-iron complexes (MNIC)/mg wet tissue) compared to control (P<0.05). NO production was significantly improved in the LPS-Arg and LPS-Cit group compared to the LPS group (P<0.0001 and P<0.05 respectively).CC BY · PubMed Central
Figure 6 Phosphorylated eNOS and iNOS protein levels in murine jejunal tissue. (A) The degree of phosphorylation of eNOS protein (expressed in arbitrary units, AU) was higher in the LPS-Cit group than in the LPS-Ala and LPS-Arg group (P<0.05). (B) The iNOS protein concentration changed in an opposite detection, with significantly lower levels in the control (P<0.05) and LPS-Cit group (P<0.01) than in the LPS-Ala and LPS-Arg group. (C) Representative examples of expression of phosphorylated eNOS (Ser 1177), iNOS and beta-actin by Western blot analysis.
Figure 6 Phosphorylated eNOS and iNOS protein levels in murine jejunal tissue. (A) The degree of phosphorylation of eNOS protein (expressed in arbitrary units, AU) was higher in the LPS-Cit group than in the LPS-Ala and LPS-Arg group (P<0.05). (B) The iNOS protein concentration changed in an opposite detection, with significantly lower levels in the control (P<0.05) and LPS-Cit group (P<0.01) than in the LPS-Ala and LPS-Arg group. (C) Representative examples of expression of phosphorylated eNOS (Ser 1177), iNOS and beta-actin by Western blot analysis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. HA Lehr, 2000, Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?, J Pathol, 190, 373, 10.1002/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(200002)190:3<373::aid-path593>3.0.co;2-3

Cited by

See all 136

Metadata

Authors
Wijnands, K. A. P., Vink, H., Briedé, J. J., van Faassen, E. E., Lamers, W. H., Buurman, W. A., & Poeze, M.
Affiliations
Maastricht University Medical Centre (NL)
Corresponding author
Wijnands, Karolina A. P.
Venue
PLoS ONE
Published
2012-05-29
Volume
7
Issue
5
Pages
e37439
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1972157068
Cited by
136
References
58
Citations by year
2026: 4 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 13 · 2020: 7 · 2019: 18 · 2018: 18 · 2017: 9 · 2016: 9 · 2015: 12 · 2014: 12 · 2013: 9 · 2012: 2
FWCI
7.50
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, cc-by)
Funders
  • Eli Lilly and Company
  • ZonMw (VENI 916.76.191)
  • European Society of Intensive Care Medicine
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
Keywords
citrulline, L-arginine, endotoxemia, nitric oxide production, endothelial nitric oxide synthase, inducible nitric oxide synthase, intestinal microcirculation, systemic inflammatory response syndrome, arginine metabolism, LPS, jejunal villi, amino acid supplementation, organ perfusion, sepsis, iNOS inhibition
MeSH terms
Animals, Arginine, Biological Availability, Citrulline, Male, Mice, Inbred C57BL, Microcirculation, Nitric Oxide, Gene Expression Regulation, Enzymologic, Endotoxemia, Dietary Supplements, Intracellular Space, Mice, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Citrulline a More Suitable Substrate than Arginine to Restore NO Production and the Microcirculation during Endotoxemia. https://app.cochat.ai/papers/10.1371/journal.pone.0037439
The paper
Wijnands, K. A. P., Vink, H., Briedé, J. J., van Faassen, E. E., Lamers, W. H., Buurman, W. A., & Poeze, M. (2012). Citrulline a More Suitable Substrate than Arginine to Restore NO Production and the Microcirculation during Endotoxemia. PLoS ONE. https://doi.org/10.1371/journal.pone.0037439

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.